Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Carol R. Thrush is active.

Publication


Featured researches published by Carol R. Thrush.


Journal of Behavioral Health Services & Research | 2004

Identifying factors critical to implementation of integrated mental health services in rural VA community-based outpatient clinics.

JoAnn E. Kirchner; Marisue Cody; Carol R. Thrush; Greer Sullivan; Carla Gene Rapp

The purpose of this study was to gain a better understanding of the critical components associated with implementing integrated mental health care services in rural VA community-based outpatient clinics (CBOCs). In-person semi-structured interviews were conducted with 20 health care providers and staff within a year after placing a trained advanced practice nurse (APN) to provide mental health/substance abuse (MH/SA) care at 2 rural CBOCs in the southeastern United States. Four raters independently evaluated interview transcripts and conducted content analysis to summarize the interview results. The results indicate that key contextual factors related to leadership, staff attitudes and beliefs, and unique organizational factors of the clinic and the community can affect the success of such clinical innovations. In addition to providing descriptive information about the attitudes, beliefs, and experiences of CBOC personnel regarding implementation of integrated MH/SA services using APNs, the study findings suggest several domains that could be explored in future studies of integrated mental health service delivery to rural veterans through primary care.


Journal of the American Medical Informatics Association | 2004

Use of Electronic Medical Record Data for Quality Improvement in Schizophrenia Treatment

Richard R. Owen; Carol R. Thrush; Dale S. Cannon; Kevin L. Sloan; Geoff Curran; Teresa J. Hudson; Mark A. Austen; Mona J. Ritchie

An understanding of the strengths and limitations of automated data is valuable when using administrative or clinical databases to monitor and improve the quality of health care. This study discusses the feasibility and validity of using data electronically extracted from the Veterans Health Administration (VHA) computer database (VistA) to monitor guideline performance for inpatient and outpatient treatment of schizophrenia. The authors also discuss preliminary results and their experience in applying these methods to monitor antipsychotic prescribing using the South Central VA Healthcare Network (SCVAHCN) Data Warehouse as a tool for quality improvement.


The Joint Commission Journal on Quality and Patient Safety | 2003

How Well Do Automated Performance Measures Assess Guideline Implementation for New-Onset Depression in the Veterans Health Administration?

Teresa L. Kramer; Richard R. Owen; Dale S. Cannon; Kevin L. Sloan; Carol R. Thrush; D. Keith Williams; Mark A. Austen

BACKGROUND Because most guidelines focus on patients with new episodes of depression, algorithms to identify such samples must be accurate. This study examined whether the Veterans Health Administrations (VHAs) electronic medical record database could identify valid cases of new-onset depression. RESULTS Of 109 individuals receiving outpatient care at one of three VHA medical centers who were identified with newly diagnosed depressive disorder, 39 (35.8%) actually had documentation of depression diagnosis and antidepressant prescription or other treatment within the previous six months. Good to excellent agreement was found between indicators of guideline-concordant care using automated and manual chart review methods. DISCUSSION Electronic medical records can validly identify many cases of new-onset depression, although with a higher-than-anticipated rate of false-positives. Half of depressed veterans received care consistent with clinical guidelines for psychopharmacological intervention, regardless of data source. SUMMARY Clinical managers, administrators, and policy advocates must weigh the cost-benefit of administrative versus medical record reviews to assess quality.


International Psychogeriatrics | 1999

Suicide among the elderly in Honolulu County: a multiethnic comparative study (1987-1992).

Don Purcell; Carol R. Thrush; Patricia L. Blanchette

Suicide rates for the elderly continue to be the highest for any age group. Although these rates are known to be significant, little study has been given to the ethnic variability associated with this phenomenon. This retrospective study was undertaken to explore this issue and involved a review of the coroners reports for completed elder suicides (65 years of age or older) for Honolulu County from 1987 through 1992 inclusive. The results showed a mean age of 75 years, with the highest incidence of completion in the 80+ age group. The predominant method of suicide completion in this study group was found to be hanging, followed by jumping, firearms, and poisoning. There were significant gender and ethnic differences in the method of suicide completion. Almost half of the sample saw a healthcare provider within the 6 months before their death. Comparisons with other elder suicide studies are presented.


Schizophrenia Research | 2003

Economic evaluations of novel antipsychotic medications: a literature review

Teresa J. Hudson; Greer Sullivan; Weiwei Feng; Richard R. Owen; Carol R. Thrush

OBJECTIVE To evaluate the evidence that novel antipsychotic medications offer a cost advantage compared to traditional antipsychotic medications. METHODS Literature for this review was identified through a computerized search of Medline, Healthstar and Psyc-INFO databases inclusive from January 1989 to January 2002. Articles included in the review were required to include cost evaluation and to be published in peer-reviewed journals. RESULTS Twenty-two studies met inclusion criteria. All five studies that used experimental designs found that second-generation antipsychotic medications were associated with a cost advantage or were cost-neutral, and, in some cases, improved quality of life. Of the ten studies using a pre-post design, four found an increase in total costs, six reported a decrease in total costs, and four reported increased effectiveness with use of a second-generation antipsychotic. All seven of the simulation studies reported a cost advantage for novel antipsychotics for specific patient populations under certain conditions. CONCLUSIONS The majority of studies found that novel antipsychotics are at least cost-neutral and may offer cost advantages compared to traditional agents. Some studies also reported greater improvement in effectiveness and quality of life when novel antipsychotics were compared to traditional antipsychotic medications. However, it is difficult to draw firm conclusions given the small sample sizes and limited study designs available in this literature.


Medical Care | 2008

The Effectiveness of Guideline Implementation Strategies on Improving Antipsychotic Medication Management for Schizophrenia

Richard R. Owen; Teresa J. Hudson; Carol R. Thrush; Purushottam B. Thapa; Tracey L. Armitage; Reid D. Landes

Objectives:To compare the effectiveness of a conceptually-based, multicomponent “enhanced” strategy with a “basic” strategy for implementing antipsychotic management recommendations of VA schizophrenia guidelines. Methods:Two VA medical centers in each of 3 Veterans Integrated Service Networks were randomized to either a basic educational implementation strategy or the enhanced strategy, in which a trained nurse promoted provider guideline adherence and patient compliance. Patients with acute exacerbation of schizophrenia were enrolled and assessed at baseline and 6 months and their medical records were abstracted; 291 participants were included in analyses. Logistic regression models were developed for rates of: (1) switching patients from first-generation antipsychotics (FGA) to second-generation antipsychotics (SGA), and (2) guideline-concordant antipsychotic dose. Results:Of participants prescribed FGAs at baseline, those at enhanced sites were significantly more likely than participants at basic sites to have an SGA added to the FGA during the study (29% vs. 8%; adjusted OR = 7.7; 95% CI: 2.0–30.1), but were not significantly more likely to be switched to monotherapy with an SGA (29% vs. 23%). Guideline-concordant antipsychotic dosing was not significantly affected by the intervention. Conclusions:The enhanced guideline implementation strategy increased addition of SGAs to FGA therapy, but did not significantly increase guideline-recommended switching from FGA to SGA monotherapy. Antipsychotic dosing was not significantly altered. The study illustrates the challenges of changing clinical behavior. Strategies to improve medication management for schizophrenia are needed, and must incorporate recommendations likely to emerge from recent research suggesting comparable effectiveness of SGAs and FGAs.


Science and Engineering Ethics | 2013

Relationships Between the Survey of Organizational Research Climate (SORC) and Self-Reported Research Practices

A. Lauren Crain; Brian C. Martinson; Carol R. Thrush

The Survey of Organizational Research Climate (SORC) is a validated tool to facilitate promotion of research integrity and research best practices. This work uses the SORC to assess shared and individual perceptions of the research climate in universities and academic departments and relate these perceptions to desirable and undesirable research practices. An anonymous web- and mail-based survey was administered to randomly selected biomedical and social science faculty and postdoctoral fellows in the United States. Respondents reported their perceptions of the research climates at their universities and primary departments, and the frequency with which they engaged in desirable and undesirable research practices. More positive individual perceptions of the research climate in one’s university or department were associated with higher likelihoods of desirable, and lower likelihoods of undesirable, research practices. Shared perceptions of the research climate tended to be similarly predictive of both desirable and undesirable research practices as individuals’ deviations from these shared perceptions. Study results supported the central prediction that more positive SORC-measured perceptions of the research climate were associated with more positive reports of research practices. There were differences with respect to whether shared or individual climate perceptions were related to desirable or undesirable practices but the general pattern of results provide empirical evidence that the SORC is predictive of self-reported research behavior.


Science and Engineering Ethics | 2013

Development and validation of the Survey of Organizational Research Climate (SORC).

Brian C. Martinson; Carol R. Thrush; A. Lauren Crain

Development and targeting efforts by academic organizations to effectively promote research integrity can be enhanced if they are able to collect reliable data to benchmark baseline conditions, to assess areas needing improvement, and to subsequently assess the impact of specific initiatives. To date, no standardized and validated tool has existed to serve this need. A web- and mail-based survey was administered in the second half of 2009 to 2,837 randomly selected biomedical and social science faculty and postdoctoral fellows at 40 academic health centers in top-tier research universities in the United States. Measures included the Survey of Organizational Research Climate (SORC) as well as measures of perceptions of organizational justice. Exploratory and confirmatory factor analyses yielded seven subscales of organizational research climate, all of which demonstrated acceptable internal consistency (Cronbach’s α ranging from 0.81 to 0.87) and adequate test–retest reliability (Pearson r ranging from 0.72 to 0.83). A broad range of correlations between the seven subscales and five measures of organizational justice (unadjusted regression coefficients ranging from 0.13 to 0.95) document both construct and discriminant validity of the instrument. The SORC demonstrates good internal (alpha) and external reliability (test–retest) as well as both construct and discriminant validity.


American Journal of Medical Quality | 2003

Clinical Practice Variations in Prescribing Antipsychotics for Patients With Schizophrenia

Richard R. Owen; Ellen P. Fischer; JoAnn E. Kirchner; Carol R. Thrush; D. Keith Williams; Brian J. Cuffel; Carl E. Elliott; Brenda M. Booth

Few studies have examined the variations among individual physicians in prescribing antipsychotics for schizophrenia. This study examined clinical practice variations in the route and dosage of antipsychotic medication prescribed for inpatients with schizophrenia by 11 different psychiatrists. The sample consisted of 130 patients with a DSM-III-R diagnosis of schizophrenia who had received inpatient care at a state hospital or Veterans Affairs medical center in the southeastern United States in 1992-1993. Mixed-effects regression models were developed to explore the influence of individual physicians and hospitals on route of antipsychotic administration (oral or depot) and daily antipsychotic dose, controlling for patient casemix variables (age, race, sex, duration of illness, symptom severity, and substance-abuse diagnosis). The average daily antipsychotic dose was 1092 ± 892 chlorpromazine mg equivalents. Almost half of the patients (48%) were prescribed doses above or below the range recommended by current practice guidelines. The proportion of patients prescribed depot antipsychotics was significantly different at the 2 hospitals, as was the antipsychotic dose prescribed at discharge. Individual physicians and patient characteristics were not significantly associated with prescribing practices. These data, which were obtained before clinical practice guidelines were widely disseminated, provide a benchmark against which to examine more current practice variations in antipsychotic prescribing. The results raise several questions about deviations from practice guidelines in the pharmacological treatment of schizophrenia. To adequately assess quality and inform and possibly further develop clinical practice guideline recommendations for schizophrenia, well-designed research studies conducted in routine clinical settings are needed.


Medical Teacher | 2010

A randomized controlled trial of behavior change counseling education for medical students

John J. Spollen; Carol R. Thrush; Dan Vy Mui; Majka B. Woods; Sara G. Tariq; Elizabeth Hicks

Background: Educating medical students about how to effectively counsel patients with negative health behaviors (i.e., lack of exercise, smoking) is vitally important. Behavior change counseling is a promising method that can be used by physicians to encourage positive changes in health behaviors. Purpose: To examine the effectiveness of a 2 h workshop in behavior change counseling for medical students. Methods: This study used a pre–post control group design with 35 second-year medical students who were randomly assigned to participate in a behavior change counseling intervention or wait-list control group. Student knowledge and attitudes were assessed using multiple choice items and open-ended question prompts. Student skills were assessed via performance in a standardized patient encounter rated using the Behavior Change Counseling Index (BECCI). Results: Student attitudes toward behavior change counseling were positive at both pre- and post-test assessment in both groups. Knowledge scores and BECCI total scores showed significantly greater improvement in the intervention group compared to the wait-list control group. Conclusions: This study found that a brief educational intervention had a positive impact on medical students’ knowledge and skills in behavior change counseling, and that student attitudes about the counseling method were very positive.

Collaboration


Dive into the Carol R. Thrush's collaboration.

Top Co-Authors

Avatar

Richard R. Owen

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

James A. Clardy

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

D. Keith Williams

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Teresa J. Hudson

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Matthew R. Smeds

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Frederick R. Bentley

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

JoAnn E. Kirchner

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Mary K. Kimbrough

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Molly Gathright

University of Arkansas for Medical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge